申请人:NPS PHARMACEUTICALS, INC.
公开号:EP1790337A2
公开(公告)日:2007-05-30
The present invention features compounds active at both the serotonin reuptake site and the N-methyl-D-aspartate (NMDA) receptor and the use of such compounds for treating different disorders. Compounds having activity at the serotonin reuptake site and the NMDA receptor ("multi-active compounds") can be used to treat different types of disorders such as obsessive-compulsive disorders (OCD), sleep disorders, sexual dysfunction, and eating disorders.
本发明的特点是具有在血清素再摄取位点和N-甲基-D-天门冬氨酸(NMDA)受体活性的化合物,并使用这些化合物治疗不同的疾病。具有在血清素再摄取位点和NMDA受体(“多功能化合物”)的活性的化合物可用于治疗不同类型的疾病,如强迫症障碍(OCD),睡眠障碍,性功能障碍和进食障碍。